Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation

Thromb Haemost. 2012 Jun;107(6):1188-9. doi: 10.1160/TH12-01-0005. Epub 2012 Mar 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Benzoates / administration & dosage*
  • Benzoates / adverse effects
  • Bleeding Time
  • Blood Loss, Surgical / prevention & control*
  • Coagulants / administration & dosage*
  • Coagulants / adverse effects
  • Drug Administration Schedule
  • Female
  • Genetic Predisposition to Disease
  • Heredity
  • Humans
  • Hydrazines / administration & dosage*
  • Hydrazines / adverse effects
  • Molecular Motor Proteins / genetics*
  • Mutation, Missense*
  • Myosin Heavy Chains / genetics*
  • Orthopedic Procedures / adverse effects*
  • Phenotype
  • Postoperative Hemorrhage / etiology
  • Postoperative Hemorrhage / prevention & control*
  • Pyrazoles / administration & dosage*
  • Pyrazoles / adverse effects
  • Severity of Illness Index
  • Thrombocytopenia / blood
  • Thrombocytopenia / complications
  • Thrombocytopenia / genetics*
  • Time Factors
  • Treatment Outcome

Substances

  • Benzoates
  • Coagulants
  • Hydrazines
  • MYH9 protein, human
  • Molecular Motor Proteins
  • Pyrazoles
  • Myosin Heavy Chains
  • eltrombopag